Presence of epidermal allantoin further supports oxidative stress in vitiligo

Experimental Dermatology

Volumn 17, Issue 9, 2008, Pages 761-770

  Shalbaf, Mohammad ^a   Gibbons, Nicholas C J ^a,b   Wood, John M ^a   Maitland, Derek J ^a   Rokos, Hartmut ^a,b   Elwary, Souna M ^a   Marles, Lee K ^a   Schallreuter, Karin U ^a,b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Allantoin; Human epidermis; Hydrogen peroxide; Vitiligo; Xanthine oxidase

Indexed keywords

ALLANTOIN; HYDROGEN PEROXIDE; METHIONINE; TRYPTOPHAN; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ARTICLE; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; COMPUTER MODEL; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; KERATINOCYTE; MASS SPECTROMETRY; MELANOCYTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VITILIGO; WESTERN BLOTTING;

ALLANTOIN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CATALYTIC DOMAIN; CELLS, CULTURED; COMPUTER SIMULATION; EPIDERMIS; FLAVIN-ADENINE DINUCLEOTIDE; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; MODELS, CHEMICAL; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; RNA, MESSENGER; URIC ACID; VITILIGO; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

EID: 49149114997     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00697.x     Document Type: Article

References (36)

1. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999: 4: 91-96.
2. Schallreuter K U. A review of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol (Noisy-le-grand) 1999: 45: 943-949.
3. Wood J M, Chavan B, Hafeez I, Schallreuter K U. Regulation of tyrosinase by tetrahydropteridines-what is real? A critical re-analysis of H. Wojtasek's view. Biochem Biophys Res Commun 2005: 331: 891-893.
4. Schallreuter K U. Functioning methionine-S-sulfoxide reductases A and B are present in human skin. J Invest Dermatol 2006: 126: 947-949.
5. 2 stress. J Invest Dermatol 2004: 122: 307-313.
6. 4-dependent processes? J Invest Dermatol 2001: 116: 167-174.
7. 2: More evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2004: 315: 502-508.
8. Wood J M, Schallreuter K U. UVA-irradiated pheomelanin alters the structure of catalase and decreases its activity in human skin. J Invest Dermatol 2006: 126: 13-14.
9. 2) in the epidermis of patients with vitiligo. J Invest Dermatol 2007.
10. Schallreuter K. Oxidative stress in human epidermis. G Ital Dermatol Venereol 2005: 140, No. 5: 505-514.
11. Hille R, Nishino T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995: 9: 995-1003.
12. Glantzounis G K, Tsimoyiannis E C, Kappas A M, Galaris D A. Uric acid and oxidative stress. Curr Pharm Des 2005: 11: 4145-4151.
13. Enroth C, Eger B T, Okamoto K, Nishino T, Nishino T, Pai E F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci U S A 2000: 97: 10723-10728.
14. Al-Khalidi U A, Chaglassian T H. The species distribution of xanthine oxidase. Biochem J 1965: 97: 318-320.
15. Parks D A, Granger D N. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand Suppl 1986: 548: 87-99.
16. Mathews C K, van Holde K E, Ahern K G. Biochemistry. Benjamin/Cummings, an imprint of Addison Wesley Longman, San Francisco, CA, USA, 2000.
17. Nishino T, Okamoto K, Kawaguchi Y et al. Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: Identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant. J Biol Chem 2005: 280: 24888-24894.
18. Benzie I F, Chung W, Tomlinson B. Simultaneous measurement of allantoin and urate in plasma: Analytical evaluation and potential clinical application in oxidant: antioxidant balance studies. Clin Chem 1999: 45: 901-904.
19. Grootveld M, Halliwell B. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo? Biochem J 1987: 243: 803-808.
20. Kaur H, Halliwell B. Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact 1990: 73: 235-247.
21. Yardim-Akaydin S, Sepici A, Ozkan Y, Simsek B, Sepici V. Evaluation of allantoin levels as a new marker of oxidative stress in Behcet's disease. Scand J Rheumatol 2006: 35: 61-64.
22. Yardim-Akaydin S, Sepici A, Ozkan Y, Torun M, Simsek B, Sepici V. Oxidation of uric acid in rheumatoid arthritis: Is allantoin a marker of oxidative stress? Free Radic Res 2004: 38: 623-628.
23. Koca R, Armutcu F, Altinyazar H C, Gurel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004: 29: 406-409.
24. Fitzpatrick T B, Miyamoto M, Ishikawa K. The evolution of concepts of melanin biology. Arch Dermatol 1967: 96: 305-323.
25. Spencer J D, Chavan B, Marles L K, Kauser S, Rokos H, Schallreuter K U. A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. J Endocrinol 2005: 187: 293-302.
26. Spencer J D, Gibbons N C, Rokos H, Peters E M, Wood J M, Schallreuter K U. Oxidative stress via hydrogen peroxide affects Pro-opiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 2006: 127: 411-420.
27. Xu P, Huecksteadt T P, Hoidal J R. Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). Genomics 1996: 34: 173-180.
28. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968: 50: 129-137.
29. Kalb V F, Jr. Bernlohr R W. A new spectrophotometric assay for protein in cell extracts. Anal Biochem 1977: 82: 362-371.
30. Stockert A L. Spectroscopic and kinetic studies of bovine xanthine oxidase and Rhodobacter capsulatus xanthine dehydrogenase (PhD thesis). The Ohio state University, Columbus, Ohio: Department of Medical Biochemistry, 2004.
31. George S K, Dipu M T, Mehra U R, Singh P, Verma A K, Ramgaokar J S. Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr B Analyt Technol Biomed Life Sci 2006: 832: 134-137.
32. Schallreuter K U. Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Appl Skin Physiol 1999: 12: 132-138.
33. Dell'Anna M L, Ottaviani M, Albanesi V et al. Membrane lipid alterations as a possible basis for melanocyte degeneration in vitiligo. J Invest Dermatol 2007: 127: 1226-1233.
34. Maresca V, Roccella M, Roccella F et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997: 109: 310-313.
35. Newsholm E A, Leech A R. Biochemistry for the Medical Sciences. John Wiley & Sons, Inc., Wiley Europe Ltd, Chicheste, UK, 1984.
36. Simoyi M F, Falkenstein E, Van Dyke K, Blemings K P, Klandorf H. Allantoin, the oxidation product of uric acid is present in chicken and turkey plasma. Comp Biochem Physiol B Biochem Mol Biol 2003: 135: 325-335.